KURA ONCOLOGY, INC. and , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Preferred Stock Warrant Agreement • December 7th, 2020 • Kura Oncology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2020 Company Industry JurisdictionPREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between KURA ONCOLOGY, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
KURA ONCOLOGY, INC. and , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Common Stock Warrant Agreement • December 7th, 2020 • Kura Oncology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2020 Company Industry JurisdictionCOMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between KURA ONCOLOGY, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
KURA ONCOLOGY, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20Debt Securities Warrant Agreement • December 7th, 2020 • Kura Oncology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 7th, 2020 Company Industry JurisdictionDEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between KURA ONCOLOGY, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).